Penis Enlargement Device and Genetic Factors

Penis enlargement device can work to provide greater penis size over potential risk factors like hypertension, diabetes and nicotine use. The penis growth achieved is not lost on discontinuation of use of traction device.

Penis enlargement device is the only effective way to achieve permanent penis growth without complications. There are no risk factors and are not governed by age as a high limiting factor. The human cell is said to contain forty six chromosomes.

About forty six chromosomes out of these are autosomes while the other two are sex chromosomes. There is pairing of individual chromosome. Every cell in the body has twenty pairs of autosomes and one pair of sex chromosomes.

Penis enlargement device works on the ability of each of the above cell to undergo mitotic multiplication as a form of regeneration. Traction devices act externally without the limitations of oral route for sexual enhancement.

Drugs are administered in multiple ways for many purposes. The appropriate route of administration depends on the patient and drug employed. 

Penis enlargement device with regular use increases penile length by about two inches in about six weeks. The average increase in visible length can be observed in tow weeks. The uniform increase in flaccid and erect measures assures high aesthetic appeal.

There is no risk to nodular and scar formation unlike that of penis enhancement surgery. The poisonous effect of drugs and chemicals can be harmful to sexual health. The household chemicals encountered often are industrial, agricultural and homicidal components.

Penis enlargement device as a medical appliance that acts externally circumvents the limitations of oral drugs. The risk to adverse drug reactions cannot be employed in this condition.

There is no pharmacological and therapeutic action. The sexual effects brought about by traction device are not dependent on quality, purification and synthesis of pharmacological agents.

The benefits derived cannot be limited by pharmaceutics. Penis enlargement device as a medical appliance has been designed with precise surgical measurements. They are not designed to alter physiology by a higher degree thus the lower risk to sexual effects.

There is no immune reaction in the form of inhibition, killing or destruction of harmful cells with infective conditions. There is no risk to unintended pharmacodynamic effects in the device recipient. Factors like safety, trial results and recipient surveillance are not applicable to traction devices.

Penis enlargement device does not work like oral drugs to bring about sexual enhancement. Traction device beneficial actions are independent of physical and chemical properties unlike prescription drugs. Diminishing factors for efficacy include solubility, stability and pH interference.

The site of desired action is local, approachable for traction device. Oral have target organ as generalized and non approachable. Penis enlargement device can be combined with local penis enhancement exercises to accelerate organ growth.

There is no limitation in pharmacologic action with traction devices as the rate and extent of absorption is unlike prescription drugs.

Gastric factors like digestive juices, first pass metabolism and efficacy are not part of therapeutic action.

Find out NOW who the top 5 extenders are!